Busca, A <br/><br/>
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Jun 2007 
 - 102-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1398-2273 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-3062.2006.00183.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Cytomegalovirus Infections--drug therapy<br/>Female<br/>Ganciclovir--administration & dosage<br/>Gastrointestinal Diseases--metabolism<br/>Graft vs Host Disease--metabolism<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Transplantation, Homologous<br/>Valganciclovir